lobbying_activities: 2503682

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2503682	06c4e270-b41c-4b96-b5cf-84d1a1b35621	Q3	AMERICAN CAPITOL GROUP	305852	IPSEN BIOPHARMACEUTICALS, INC.	2020	third_quarter	HCR	Orphan Drugs, CHIP reauthorization, Health Reform, Drug Pricing issues	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2020-10-03T15:14:45.323000-04:00